Search
+
    SEARCHED FOR:

    STOCKS IN FOCUS

    European stocks wrap up week on a high note; focus shifts to Fed's rate decision

    European stocks ended the week positively, driven by technology, real estate, and mining shares. The STOXX 600 index rose 0.7%, with German shares leading gains. Investors are now focused on the U.S. Federal Reserve's upcoming meeting, anticipating a potential rate cut. ECB policymakers remain optimistic about lower inflation and interest rates in the euro zone.

    MFs add stocks with focus on likely rate cuts, cheaper oil

    In August, mutual fund managers focused on stocks poised to benefit from potential rate cuts and falling crude prices, accumulating shares in paints, tyre companies, and select banks and NBFCs like Kotak and IndusInd.

    European shares jump 1% on tech boost; ECB meet in focus

    Basic resources gained 2% after prices of base metals rose, buoyed by hopes of an interest rate reduction in the U.S. next week..

    Best focused mutual funds to invest in September 2024

    According to Sebi norms, focused equity mutual fund schemes must invest in a portfolio of maximum 30 stocks. These schemes have no other restrictions when it comes to investing- like flexi cap schemes they can invest in any market capitalisations and sectors. If that investment strategy appeals to you, you can get to know more about focused equity schemes.

    US stocks bounce as focus shifts to rates outlook ahead of inflation data

    Wall Street's main indexes opened higher on Monday following heavy losses last week, as investors remained optimistic about soft landing prospects for the U.S. economy ahead of a crucial inflation report later in the week.

    Corrections are part of market, focus on owning correct business: 6 midcap stocks from different sectors with an upside potential of upto 24 %

    While a correction had been happening on the street, with one sector witnessing a decline while other moved up. But on Friday, there was a sharp correction both at the level of Nifty, Sensex and market breadth. It was across the sectors. Reasons might be different but it is not the first time nor the last time that such a correction has taken place, they are part of the market and will keep happening at regular intervals. But as an investor the correction has to be on owning the correct business and not corrections. Now what is a correct business ? Simple, a track record of growth and sharing it with minority investors.

    • Vedanta, BEML, among 140 stocks to remain in focus next week for dividend, bonus, split. Do you own any?

      The record date is the date set by the company to decide the shareholders who are eligible to receive the offer. To be eligible for a buyback offer, bonus issue or a stock split, the shares should be in the demat account on the record date.

      Wall St ends lower as tech shares weigh; Jackson Hole in focus

      U.S. stock markets faced declines on Thursday with technology shares leading the fall as Treasury yields rose and global central bank officials met at the Jackson Hole Economic Symposium. Investors are keenly awaiting Federal Reserve Chair Jerome Powell's speech for insights on potential rate cuts.

      Japan's Nikkei ends at 3-week high; focus on central bankers' comments

      The market was cautious ahead of the remarks by the Bank of Japan Governor (Kazuo) Ueda as well as Federal Reserve Chair (Jerome) Powell later this week," said Shuutarou Yasuda, a market analyst at Tokai Tokyo Intelligence Laboratory

      S&P 500, Nasdaq edge up after payrolls revisions; Fed minutes in focus

      The S&P 500 and Nasdaq edged up after a revision in U.S. payrolls data. Investors awaited minutes from the Federal Reserve's meeting amid speculations of a rate cut. Financial markets had a mixed response, with gains for consumer staples and declines for certain tech and retail stocks, including Macy's and Chinese e-commerce.

      US stocks slip at open with Fed in focus

      The Dow Jones Industrial Average fell 22.0 points, or 0.05%, at the open to 40,874.52

      Focus on large deals, AI crucial for Sonata amid short term hiccups

      Sonata provides solutions to modernise the technology infrastructure used by clients across verticals including banking, financial services and insurance (BFSI), healthcare, retail, manufacturing, travel, media and telecom around the world. For the international business, the company has a high client concentration with top 10 customers contributing half of the segment revenue.

      Ola Electric shares in focus ahead of Q1 results; stock up 49% since listing

      Ola Electric Share Price: Ola Electric shares, up 49% since their listing, are in focus as the company prepares to announce its first-quarter results for FY2025. The board's first post-listing meeting is scheduled for August 14, where the Q1 results for FY2025 will be revealed.

      Stocks in news: Hero MotoCorp, Hindalco, Apollo Hospitals, Vedanta, Ola Electric

      On Tuesday, the Sensex dropped nearly 700 points, extending the market's losses. Key stocks such as Hero MotoCorp, Hindalco, Apollo Hospitals, and Vedanta were in focus due to new developments and quarterly results. Hero MotoCorp and Apollo Hospitals reported strong profit growth, while IRCTC and Nykaa also showed impressive gains.

      Wall Street mixed ahead of economic data; CPI in focus

      Wall Street ended with mixed results as investors awaited key U.S. economic data and retailer earnings. The Dow Jones fell, while the S&P 500 and Nasdaq saw gains. Key points of interest include the consumer price index and retail sales data, along with potential Federal Reserve policy changes. KeyCorp surged on news of Scotiabank's investment.

      Big movers on D-Street: What should investors do with Voltas, RVNL and MapMyIndia?

      Stocks that were in focus include names like Voltas, which rose 10.69%, RVNL, which jumped 11.16%, and MapMyIndia, whose shares increased 3.75% on Monday.

      Stocks in news: Grasim, Info Edge, LIC, Eicher Motors, SAIL

      Thursday's market closed in red due to the RBI's cautious policy. Key events included LIC's 9% profit rise, Eicher Motors’ 20% increase, and Cochin Shipyard's 76.6% growth. Additionally, Trent, Grasim, and Info Edge announced their Q1 results, among other notable financial updates from various firms.

      Stocks in news: LIC, RVNL, BSE, Hindalco, Tata Motors, Eicher Motors

      The domestic markets rebounded on Tuesday, gaining over a percent owing to robust global cues. Stocks such as LIC, Eicher Motors, RVNL, and Tata Motors were highlighted due to quarterly results and corporate developments. Key financial outcomes were reported by BSE, NHPC, and Apollo Tyres. Moody's upgraded Tata Motors' rating, keeping a positive outlook.

      Stocks in news: Pidilite, Godrej Consumer, PB Fintech, Gland Pharma, Tata Power

      Tuesday saw Indian markets close marginally lower amid volatility and mixed signals. Companies like Pidilite, Godrej Consumer, and NHPC announced their first-quarter results. Noteworthy financial updates were reported by PB Fintech, Tata Power, and others. In a significant move, Challa Sreenivasulu Setty was appointed as the chairman of SBI.

      Stocks in news: RIL, Bharti Airtel, Vedanta, Tata Power, Lupin

      Indian benchmark indices plummeted almost 3% on Monday amid global market shocks and concerns over a US economy slowdown. RIL, Bharti Airtel, Vedanta, Tata Power, and other major companies were highlighted due to recent news and quarterly results. RIL’s AGM is on August 29, while ONGC and Airtel disclosed contrasting profit performances.

      Stock Radar: Chemical stocks in focus! NOCIL hits record high in August; what should investors do?

      NOCIL Ltd, in the specialty chemical sector, saw a nearly 20% rally in the last 3 months, reaching a new record high in August 2024, indicating that the bullish trend may persist. Experts suggest short-term traders target Rs 370 over the next 3-4 weeks.

      Stocks in news: SBI, Airtel, ONGC, Titan, Infosys, JSW Steel, IDBI Bank

      The past week saw domestic markets close marginally lower amid volatility. Key highlights included SBI's 0.9% rise in Q1 net profit, Titan’s slight profit decrease, and Divi's Labs' 21% profit growth. Airtel, ONGC, and Marico were noted for upcoming Q1 results, while Infosys had significant regulatory updates.

      Stock Radar: Pharma stocks back in focus! Sun Pharma likely to surpass April 2024 highs

      Sun Pharma Ltd rose by over 17% since June 2024, hitting above Rs 1,300 levels. Experts suggest that if the momentum continues, the stock could reach Rs 1,700. Pharmaceutical stocks are gaining attention as safer defensive options amid a volatile market. Short-term traders are advised to consider it for potential gains.

      Infrastructure push in Eastern India, opportunity for select cement makers: 5 cement stocks with an upside potential of up to 37%

      Sometimes, what is considered a weakness by the street turns into an opportunity by just one policy announcement. Take the case of cement companies which are focussed on the eastern part of the country. The special push to the infrastructure sector in the eastern part of the country is likely to help companies which are primarily focussed in that region. Indian cement companies can be divided into two categories, one which are present in a particular region and other which have a pan India presence. Normally it is pan India companies which get better valuation because if there is an issue with sales in one region, it is made up by that of another. Regional focussed companies tend to get less attention, but for some which are focussed in eastern and southern parts, probably there are better times ahead.

      US stocks open muted, quarterly results of Alphabet, Tesla, tech stocks in focus

      Wall Street opened cautiously on Tuesday amid varied corporate results, with investors awaiting Alphabet and Tesla's earnings. They seek clues on whether the market's recent record gains can sustain.

      Rail, defence, PSU stocks in focus ahead of Budget

      Railway, defence, and PSU stocks on BSE rose ahead of the Union Budget by the Finance Minister. RailTel up 3%, Cochin Shipyard and DCX Systems gained, while Titagarh Rail, Texmaco Rail mixed. PSU stocks: IRCTC, IRFC, OIL, GMDC, Mazagon Dock, Bharat Forge, LIC, BEML, NTPC, Gujarat Gas, RCF, NMDC Steel. Multibagger returns seen; MRPL declined 3.7%.

      Budget 2024: Realty sector expects higher outlay for PMAY, home loan interest deduction limit raise

      Favorable announcements in the housing sector could boost stocks of realty, cement, and housing finance companies. Credit ratings agency CareEdge predicts the government will increase funding for affordable housing schemes, driving construction and employment.

      These largecaps have ‘strong buy’ & ‘buy’ recos and upside potential of more than 23%

      A simple question which probably has the most complex answer. Till date which set of stocks have delivered best returns in 2024. Last year the narrative was about mid and small caps having outperformed the large caps. In the first half of 2024, there is no such narrative and no clear answer. There is historical evidence that when this happens in the next six to nine months, it is large caps which tend to perform well. This happens due to high valuation differential in mid and large caps is bound to reduce as mean reversion takes place. ET screener powered by Refinitiv’s Stock Report Plus lists down quality stocks with high upside potential over the next 12 months, having an average recommendation rating of “buy” or "strong buy". The screener applies different algorithms for all BSE and NSE stocks.

      Pharma sector: Turnaround for good, 6 small and mid cap pharma stocks with upside potential of up to 32%

      While it might not have been making it headline, the pharmaceutical sector or commonly called as pharma has come through a tough period due to US FDA and other factors. It has been witnessing a turnaround of sorts which has been slow but more companies are showing improvement in their performance. Also there is a process of re-rating which is quietly going on in the sector. It was large players which got the attention of tend to gain first and then it is smaller and mid sized. If one looks at the corporate announcement about approval of drugs by the US FDA or other drug regulator or any entry into new markets, a number of them are coming from mid and small companies. Given the lesson which the Indian pharma industry has learnt after its reckless approach between 2005 to 2015, there is a high probability that the sector may gain attention.

      Load More
    The Economic Times
    BACK TO TOP